03:12 AM EDT, 06/06/2024 (MT Newswires) -- Jay Lichter, 10% Owner, Director, on June 03, 2024, sold 1,500,000 shares in Janux Therapeutics ( JANX ) for $82,125,000. Following the Form 4 filing with the SEC, Lichter has control over a total of 3,344,601 shares of the company, with 4,583 shares held directly and 3,340,018 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1817713/000141588924015678/xslF345X03/form4-06052024_110623.xml

Price: 49.10, Change: +2.33, Percent Change: +4.98